Impact of highly purified urinary FSH and recombinant FSH on haemostasis: An open-label, randomized, controlled trial

Human Reproduction

Volumn 19, Issue 4, 2004, Pages 838-848

  Ricci, G ^a   Cerneca, F ^b   Simeone, R ^b   Pozzobon, C ^a   Guarnieri, S ^a   Sartore, A ^a   Pregazzi, R ^a   Guaschino, S ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Haemostasis; Highly purified urinary FSH; Menstrual cycle; Pregnancy; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; PROTEIN C; PROTEIN S; PROTHROMBIN; RECOMBINANT FOLLITROPIN; TISSUE PLASMINOGEN ACTIVATOR; UROFOLLITROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HEMOSTASIS; HUMAN; LUTEAL PHASE; MENSTRUATION; OVULATION; PARTIAL THROMBOPLASTIN TIME; PREGNANCY RATE; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VEIN THROMBOSIS;

EID: 1842480462     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh185     Document Type: Article

References (46)

1. Aune B, Hoie KE, Oian P, Holst N and Osterud B (1991) Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state? Hum Reprod, 6,925-927.
2. Aune B, Øian P and Østerud B (1993) Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in-vitro fertilization. Hum Reprod 8,1349-1352.
3. Belaen B, Geerinckx K, Vergauwe P and Thys J (2001) Internal jugular vein thrombosis after ovarian stimulation. Hum Reprod 16,510-512.
4. Benedetto C, Marozio L, Tavella AM, Maula V, Carmignani D and Curti A (2002) Response to activated protein C decreases throughout pregnancy. Acta Obstet Gynecol Scand 81,1028-1032.
5. Biron C, Galtier-Dereure F, Rabesandratana H, Bernard I, Aguilar-Martinez P, Schved JF and Hedon B (1997) Hemostasis parameters during ovarian stimulation for in vitro fertilization: Results of a prospective study. Fertil Steril 67,104-109.
6. Bremme K, Wramsby H, Andersson O, Wallin M and Blomback M (1994) Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation? Blood Coagul Fibrinolysis 5,205-210.
7. Cederbland G, Hahn L, Korsan-Bengtsen K, Pehrsson NG and Rybo G (1977) Variation in blood coaugulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle. Haemostasis 6,294-302.
8. Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S and Guaschino S (1997) Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 73,31-36.
9. Clark P, Brennand J, Conkie JA., McCall F, Greer IA and Walker ID (1998) Activated protein C sensitivity, protein C, protein S and coaugulation in normal pregnancy. Thromb Haemost 79,1166-1169.
10. Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Gavazzi L, et al. (1992) The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb 12,1063-1070.
11. Curvers J, Nap AW, Thomassen MC, Nienhuis SJ, Hamulyak K, Evers JL, Tans G and Rosing J (2001) Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway. Br J Haematol 115,400-407.
12. Dahlback B (1984) Interaction between vitamin K-dependent protein S and the complement protein, C4b-binding protein: A link between coagulation and the complement system. Semin Thromb Hemost 2,39-148.
13. DeVisser MCH, Rosendaal FR and Bertina RM (1999) A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 93,1271-1276.
14. Duc-Goiran P, Mignot TM, Bourgeois C and Ferré F (1999) Embryo-maternal interactions at the implantation site: A delicate equilibrium. Eur J Obstet Gynecol Reprod Biol 83,85-100.
15. Espey LL (1980) Ovulation as an inflammatory reaction - A hypothesis. Biol Reprod 22,73-106.
16. Falkon L, Garì M, Garcìa Mora JL, Calaf J, Rodriguez Espinosa J, Oliver A and Fontcuberta J (1995) The effect of endogenous oestradiol levels on protein S concentration during a mestrual cycle and after GnRH analogues and gonadotropin therapy. Br J Haematol 90,438-441
17. Fenichel P, Donzeau M, Cervoni F, Menezo Y and Hsi BL (1995) Expression of complement regulatory proteins on human eggs and preimplantation embryos. Am J Reprod Immunol 33,155-164.
18. Gleicher N, Vietzke M and Vidali A (2003) Bye-bye urinary gonadotrophins?: Recombinant FSH: A real progress in ovulation induction and IVF? Hum Reprod 18,476-482.
19. Gorog DA, Rakhit R, Parums D, Laffan M and Davies GJ (1998) Raised factors VII is associated with coronary thrombotic events. Heart 80,415-417.
20. Grant PJ (1990) Review paper: Hormonal regulation of the acute haemostatic response to stress. Blood Coagul Fibrinolysis 1,299-306.
21. Gris JC, Jamin C, Benifla JL, Quere I, Madelenat P and Mares P (2001) APC resistance and third-generation oral contraceptives. Hum Reprod 16,3-8.
22. Hanss M, Trzeciak MC, Ninet J, Jurus C, Boulieu D and Dechavanne M (1993) Decreased plasma fibrin degradation products during hormonal stimulation for in vitro fertilisation. Fibrinolysis 7,341-346.
23. Henkens CMA, Born VJJ, Seinen AJ and van der Meer J (1995) Sensitivity to activated Protein C; influence of oral contraceptives and sex. Thromb Haemost 73,402-404.
24. Kapiotis S, Jilma B, Pernerstorfer T, Stohlawetz P, Eichler HG and Speiser W (1998) Plasma levels of activated factor VII decrease during the menstrual cycle. Thromb Haemost 80,588-591.
25. Khamsi F, Armstrong DT and Zhang X (1996) Expression of urokinase-type plasminogen activator in human preimplantation embryos. Mol Hum Reprod 2,273-276.
26. Kim HC, Kemmann E, Shelden RM and Saidi P (1981) Response of blood coagulation parameters to elevated endogenous 17 beta-estradiol levels induced by human menopausal gonadotropins. Am J Obstet Gynecol 140,807-810.
27. Kjellberg U, Andersson NE, Rosén S, Tengborn L and Hellgren M (1999) APC Resistance and other Haemostatic Variables during Pregnancy and Puerperium. Thromb Haemost 81,527-531.
28. Lebech AM, Kjaer A and Lebech PE (1990) Metabolic changes during the normal mestrual cycle: A longitudinal study. Am J Obstet Gynecol 163,414-416.
29. Lockwood CJ, Krikun G and Schatz F (1999) The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol 17,45-51.
30. Loret de Mola JR, Kiwi R, Austin C and Goldfarb JM (2000) Subclavian deep vein thrombosis associated with the use of recombinant follicle-stimulating hormone (Gonal-F) complicating mild ovarian hyperstimulation syndrome. Fertil Steril 73,1253-1256.
31. Lox C, Canez M, DeLeon F, Dorsett J and Prien S (1995) Hyperstrogenism induced by menotropins alone or in vitro conjuction with luprolide acetate in in vitro fertilization cycle: The impact on hemostasis. Fertil Steril 63,566-570.
32. Lox C, Canez M and Prien S (1998) The influence of hyperestrogenism during in vitro fertilization on the fibrinolytic mechanism. Int J Fertil Womens Med 43,34-39.
33. Ludwig M, Felberbaum RE and Diedrich K (2000) Deep vein thrombosis during administration of HMG for ovarian stimulation. Arch Gynecol. Obstet 263,139-141.
34. Magnani B, Tsen L, Datta S and Bader A (1999) In vitro fertilization: Do short-term changes in estrogen levels produce increased fibrinolysis? Am J Clin Pathol 112,485-491.
35. Malm J, Laurell M and Dahlback B (1988) Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 68,437-443.
36. McVey JH (1999) Tissue factor pathway. Baillieres Clin Haematol 12,361-372.
37. Mozes M, Bogokowsky H, Antebi E, Lunenfeld B, Rabau E, Serr DM, David A and Salomy M (1965) Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet 2,1213-1215.
38. Olivieri O, Friso S, Manzato F, Guella A, Bernardi F, Lunghi B, Girelli D, Azzini,M, Brocco G, Russo C et al. (1995) Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol 91,465-470.
39. Osterud B, Robertsen R, Asvang GB and Thijssen F (1994) Resistance to activated protein C is reduced in women using oral contraceptives. Blood Coagul Fibrinolysis 5,853-854.
40. Phillips LL, Gladstone W and vande Wiele R (1975) Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins. J Reprod Med 14,138-143.
41. Rice MVC, Richard-Davis G, Saleh AA, Ginsburg KA, Mammen EF, Moghissi K and Leach R (1993) Fibrinolytic parameters in women undergoing ovulation induction. Am J Obstet Gynecol 169,1549-1553.
42. Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Buller HR, Prins MH and Tans G (1999) Low-dose oral contraceptives and acquired resistance to activated protein C: A randomised cross-over study. Lancet 354,2036-2040.
43. Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Buller HR and Rosing J (2000) A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost 84,15-21.
44. Tans G, Van Hylckama Vlieg A, Thomassen MC, Curvers J, Bertina RM, Rosing J and Rosendaal FR (2003) Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. Br J Haematol 122,465-470.
45. Taylor CT and Johnson PM (1996) Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes. Mol Hum Reprod 2,52-59.
46. Wramsby ML, Bokarewa MI, Blomback M and Bremme AK (2000) Response to activated protein C during normal menstrual cycle and ovarian stimulation. Hum Reprod 15,795-797.